147 related articles for article (PubMed ID: 35714449)
1. Generation of a human embryonic stem cell line (SMUDHe010-A-82) carrying a homozygous c.1538G > A (p.G513D) mutation in the OSMR gene by CRISPR/Cas9-mediated homologous recombination.
Zheng W; Zhong Y; Yuan L; Yu X; Wang X; Yang C; Liu H; Lv P; Luo Y; Qiu B; Liu J; Yang B
Stem Cell Res; 2022 Aug; 63():102842. PubMed ID: 35714449
[TBL] [Abstract][Full Text] [Related]
2. AHNAK, regulated by the OSM/OSMR signaling, involved in the development of primary localized cutaneous amyloidosis.
Liu H; Qiu B; Yang H; Zheng W; Luo Y; Zhong Y; Lu P; Chen J; Luo Y; Liu J; Yang B
J Dermatol Sci; 2023 May; 110(2):53-60. PubMed ID: 37100691
[TBL] [Abstract][Full Text] [Related]
3. Generation of a human embryonic stem cell line (SMUDHe010-A-1B) carrying inducible DTA expression cassette in the AAVS1 locus by CRISPR/Cas9-mediated homologous recombination.
Qiu B; Zheng W; Zhong Y; Liu H; Yu J; Luo Y; Liu J; Yang B
Stem Cell Res; 2024 Feb; 74():103283. PubMed ID: 38103335
[TBL] [Abstract][Full Text] [Related]
4. RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D.
Qi XP; Zhao JQ; Chen ZG; Cao JL; Du J; Liu NF; Li F; Sheng M; Fu E; Guo J; Jia H; Zhang YM; Ma JM
Oncotarget; 2015 Oct; 6(32):33993-4003. PubMed ID: 26356818
[TBL] [Abstract][Full Text] [Related]
5. Generation of a human embryonic stem cell line (SMUDHe010-A-1A) carrying Brainbow cassette in the AAVS1 gene by CRISPR/Cas9-mediated homologous recombination.
Luo Y; Zheng W; Zhong Y; Liu H; Yu J; Qiu B; Liu J; Yang B
Stem Cell Res; 2024 Mar; 77():103383. PubMed ID: 38507883
[TBL] [Abstract][Full Text] [Related]
6. OSMRβ mutants enhance basal keratinocyte differentiation via inactivation of the STAT5/KLF7 axis in PLCA patients.
Liu J; Chen J; Zhong Y; Yu X; Lu P; Feng J; Zhang X; Ma S; Yang C; Yang B; Rong Z
Protein Cell; 2021 Aug; 12(8):653-661. PubMed ID: 33502684
[No Abstract] [Full Text] [Related]
7. Generation of RYBP FLAG-HA knock-in human embryonic stem cell line through CRISPR/Cas9-mediated homologous recombination.
Zhang J; Zhou T; Shan Y; Pan G
Stem Cell Res; 2022 Jul; 62():102803. PubMed ID: 35537243
[TBL] [Abstract][Full Text] [Related]
8. Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9.
Kim SJ; Habib O; Kim JS; Han HW; Koo SK; Kim JH
Stem Cell Res; 2017 Mar; 19():46-48. PubMed ID: 28413005
[TBL] [Abstract][Full Text] [Related]
9. A new c.1845A→T of oncostatin M receptor-β mutation and slightly enhanced oncostatin M receptor-β expression in a Chinese family with primary localized cutaneous amyloidosis.
Wang WH; Li LF; Huang ES; Zhang Q; Sun TT; Song QH; Xu ML; Chen XR
Eur J Dermatol; 2012; 22(1):29-33. PubMed ID: 22062952
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic features of Chinese patients with lichen and macular primary localized cutaneous amyloidosis.
Lu P; Wu FF; Rong ZL; Fang C; Deng CC; Bin LH; Yang B
Clin Exp Dermatol; 2019 Jun; 44(4):e110-e117. PubMed ID: 30734345
[TBL] [Abstract][Full Text] [Related]
11. Generation of an Abcc8 homozygous mutation human embryonic stem cell line using CRISPR/Cas9.
Guo D; Liu H; Gao G; Ruzi A; Wang K; Wu H; Lai K; Liu Y; Yang F; Lai L; Li YX
Stem Cell Res; 2016 Nov; 17(3):640-642. PubMed ID: 27934599
[TBL] [Abstract][Full Text] [Related]
12. Generation of a KLF15 homozygous knockout human embryonic stem cell line using paired CRISPR/Cas9n, and human cardiomyocytes derivation.
Noack C; Haupt LP; Zimmermann WH; Streckfuss-Bömeke K; Zelarayán LC
Stem Cell Res; 2017 Aug; 23():127-131. PubMed ID: 28925362
[TBL] [Abstract][Full Text] [Related]
13. Generation of an S100B homozygous knockout pluripotent stem cell line (WAe009-A-94) by the CRISPR/Cas9 system.
Zhang P; Wang H; Li S; Guo T; Zhang R; Zhou P; Ding S
Stem Cell Res; 2022 Oct; 64():102924. PubMed ID: 36182708
[TBL] [Abstract][Full Text] [Related]
14. Generation of a TLE1 homozygous knockout human embryonic stem cell line using CRISPR-Cas9.
Herring A; Messana A; Bara AM; Hazelbaker DZ; Eggan K; Barrett LE
Stem Cell Res; 2016 Sep; 17(2):430-432. PubMed ID: 27879218
[TBL] [Abstract][Full Text] [Related]
15. Generation of an ASGR1 homozygous mutant human embryonic stem cell line WAe001-A-6 using CRISPR/Cas9.
Xu Y; Wu Y; Guo D; Gao G; Lai K; Yang F; Wang K; Wu H; Lai L; Li J; Xu K; Li YX
Stem Cell Res; 2017 Jul; 22():29-32. PubMed ID: 28952928
[TBL] [Abstract][Full Text] [Related]
16. Generation of a SMO homozygous knockout human embryonic stem cell line WAe001-A-16 by CRISPR/Cas9 editing.
Wu F; Gao G; Pan T; Yang Z; Xu G; Abbas N; Liu Y; Chen Y; Tan S; You K; Ke X; Zhuang Y; Lin X; Yang F; Li YX
Stem Cell Res; 2018 Mar; 27():5-9. PubMed ID: 29278761
[TBL] [Abstract][Full Text] [Related]
17. Generation of a GDE heterozygous mutation human embryonic stem cell line WAe001-A-14 by CRISPR/Cas9 editing.
Xu G; Guo D; Wu F; Abbas N; Lai K; Yuan F; You K; Liu Y; Zhuang Y; Wu Y; Xu Y; Chen Y; Yang F; Pan T; Li YX
Stem Cell Res; 2018 Mar; 27():38-41. PubMed ID: 29310060
[TBL] [Abstract][Full Text] [Related]
18. Generation of a Well-Characterized Homozygous Chromodomain-Helicase-DNA-Binding Protein 4
Chohra I; Giri S; Malgrange B
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445725
[TBL] [Abstract][Full Text] [Related]
19. The establishment of a homozygous SNTA1 knockout human embryonic stem cell line (WAe009-A-50) using the CRISPR/Cas9 system.
Dong T; Zhang S; Chang Y; Bai R; Jiang Y; Ma S; Li Y; Jiang HF; Lu WJ
Stem Cell Res; 2021 Mar; 51():102196. PubMed ID: 33524674
[TBL] [Abstract][Full Text] [Related]
20. Generation of FHL2 homozygous knockout lines from human embryonic stem cells by CRISPR/Cas9-mediated ablation.
Chang CW; Chang CC; Hsia KC; Tsai SY
Stem Cell Res; 2018 Mar; 27():21-24. PubMed ID: 29291512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
